logo
Global vaccine and health bodies could team up more to tackle US-led funding crisis

Global vaccine and health bodies could team up more to tackle US-led funding crisis

Straits Times22-05-2025

Global vaccine and health bodies could team up more to tackle US-led funding crisis
LONDON - Two global health groups that fund billions of dollars worth of critical medical aid - from childhood vaccines to malaria treatments - are in talks about merging some functions to help combat a financing crunch, their chief executives told Reuters.
The groups – the Global Fund to Fight AIDS, Tuberculosis and Malaria and the vaccine group Gavi – said they had been discussing working more efficiently together for several years, but a massive pull-back on government-funded aid budgets, led by the Trump administration, has given the talks more urgency.
'I think the crisis – and it is a crisis, what we're facing in global health right now – is an impetus to think hard about the shape and structure of the global health ecosystem,' Peter Sands, chief executive of the Global Fund, told Reuters.
Gavi and the Global Fund set up a working group in autumn last year to work more closely together and explore merging some functions, joined by the World Bank's Global Financing Facility for women and girls. The group's work, which is ongoing, has not been previously reported.
'The idea is not to bring these massive structures together, the idea is to work better at the country level… to make life for countries easier,' said Sania Nishtar, Gavi chief executive.
Sands and Nishtar spoke to Reuters during the World Health Organization's annual meeting in Geneva, at which budget cuts and efficiencies were high on the agenda.
Nishtar gave an example of Gavi in Nigeria helping local health officials give children measles and rubella vaccines, while Global Fund supported them giving bed nets to their parents to help prevent malaria. Previously, the two groups might have had separate desks, supply chains, data, staff, logistics, and guidelines, and even warehouses. That should be done better, she said.
Working together on rolling out the malaria vaccine, led by Gavi, alongside other malaria tools like preventive drugs, which the Global Fund manages, had also prompted greater cooperation.
The Global Fund is trying to raise $18 billion for its work from 2027-2029, and Gavi is trying to raise $9 billion for 2026-2030.
Donors told Reuters that they are pushing for efficiencies as they consider how much to pledge to the groups, which have saved millions of lives since beginning work in the early 2000s.
A Gavi spokesperson said it had started a voluntary departure scheme among its 650 staff and consultants and was working to streamline operations. The Global Fund has around 1,200 staff and declined to comment on potential cuts.
Advocates including Bill Gates, a major global health funder through his foundation, said he had been talking to governments about the essential role the two organisations play.
'Being an advocate and making sure the money is well-spent, that is part of my role,' he told Reuters earlier this month. REUTERS
Join ST's Telegram channel and get the latest breaking news delivered to you.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CDC expert resigns from COVID vaccines advisory role, sources say
CDC expert resigns from COVID vaccines advisory role, sources say

Straits Times

time44 minutes ago

  • Straits Times

CDC expert resigns from COVID vaccines advisory role, sources say

FILE PHOTO: Vials labelled \"VACCINE Coronavirus COVID-19\" and a syringe are seen in front of a displayed U.S. flag in this illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Pediatric infectious disease expert Dr. Lakshmi Panagiotakopoulos of the U.S. CDC resigned on Tuesday as co-leader of a working group that advises outside experts on COVID-19 vaccines and is leaving the agency, two sources familiar with the move told Reuters. Panagiotakopoulos said in an email to work group colleagues that her decision to step down was based on the belief she is "no longer able to help the most vulnerable members" of the U.S. population. In her role at the Centers for Disease Control and Prevention's working group of the Advisory Committee on Immunization Practices, she co-led the gathering of information on topics for presentation. Her resignation comes one week after Health Secretary Robert F. Kennedy Jr., a long-time vaccine skeptic who oversees the CDC, the Food and Drug Administration and the National Institutes of Health, said the COVID vaccine for healthy children and healthy pregnant women had been removed from the CDC's recommended immunization schedule. The move was a departure from the process in which ACIP experts meet and vote on changes to the immunization schedule or recommendations on who should get vaccines before the agency's director made a final call. The committee had not voted on the changes announced by Kennedy and the CDC does not yet have a permanent director. Two days after Kennedy's announcement, the CDC published a vaccine schedule online saying that COVID-19 vaccines remain an option for healthy children aged 6 months to 17 years when parents and doctors agree that it is needed. It had previously recommended updated COVID vaccines foreveryone aged six months and older, following the guidance ofthe panel of outside experts. Two sources said Panagiotakopoulos did not include a specific reason for her departure. Panagiotakopoulos did not return requests for comment. "Unfortunately for me, this is a personal decision," Panagiotakopoulos wrote in an email to members of the working group that was read to Reuters by a source who received it. "My career in public health and vaccinology started with a deep-seated desire to help the most vulnerable members of our population, and that is not something I am able to continue doing in this role." The committee is scheduled to meet on June 25-27 and is expected to deliberate and vote on recommendations for use of COVID-19 vaccines, according to one of the sources who was not authorized to speak publicly. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.

Alcaraz was way too fast for me today, says Paul after French Open exit
Alcaraz was way too fast for me today, says Paul after French Open exit

Straits Times

timean hour ago

  • Straits Times

Alcaraz was way too fast for me today, says Paul after French Open exit

Tennis - French Open - Roland Garros, Paris, France - June 3, 2025 Tommy Paul of the U.S. reacts during his quarter final match against Spain's Carlos Alcaraz REUTERS/Denis Balibouse Tennis - French Open - Roland Garros, Paris, France - June 3, 2025 Tommy Paul of the U.S. reacts during his quarter final match against Spain's Carlos Alcaraz REUTERS/Denis Balibouse Tennis - French Open - Roland Garros, Paris, France - June 3, 2025 Tommy Paul of the U.S. in action during his quarter final match against Spain's Carlos Alcaraz REUTERS/Denis Balibouse Tennis - French Open - Roland Garros, Paris, France - June 3, 2025 Spain's Carlos Alcaraz after winning his quarter final match against Tommy Paul of the U.S. REUTERS/Denis Balibouse Alcaraz was way too fast for me today, says Paul after French Open exit PARIS - Defending champion Carlos Alcaraz played too fast and too aggressively for American Tommy Paul on Tuesday as the defending champion raced through their French Open quarter-final in straight sets and 94 minutes. Paul was mauled by the Spaniard in an eye-popping near-flawless 6-0 6-1 6-4 performance with Alcaraz firing 40 winners in the process. "Not particularly fun," Paul told reporters. "He played some great tennis, returned very well, had me on my backfoot all the time, playing so fast. "Even on the changeovers he was getting up so fast with 20 seconds left. I thought I have got to slow down. He played some amazing tennis. "He was on offence and that was not what I needed tonight. I did the best I could." The world number 12, who had spent close to 11 hours on court in his previous rounds, said he had tried to slow the match down in an effort to shake his opponent out of his rhythm. "Just waiting for the chair umpire to say 'time'," Paul said. "I felt like I was sitting down and there were 20 seconds left and Carlos was already up." The American put up somewhat of a fight in the third set but had trouble with a nagging abdominal muscle injury and was also feeling pain in his adductors. "I felt better today. I want to win the match but pretty early on it was pretty obvious I was not moving amazing," Paul said. "Everyone bought tickets for the night session so I thought I try my best. Obviously I did not want it to go like that." Paul said he was still planning to defend his title at Queen's in London later this month ahead of Wimbledon after a check on the injuries. "That's the plan. It's my ab(dominal) and the adductors. A couple of things. We are going to figure that out in the next couple of days," he said. Alcaraz will face Lorenzo Musetti in the last four after the Italian downed American Frances Tiafoe in four sets. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.

Trump administration scraps Biden-era policy on emergency abortions
Trump administration scraps Biden-era policy on emergency abortions

Straits Times

timean hour ago

  • Straits Times

Trump administration scraps Biden-era policy on emergency abortions

FILE PHOTO: Abortion rights supporters hold placards on the day the Supreme Court justices hear oral arguments over the legality of Idaho's Republican-backed, near-total abortion ban in medical-emergency situations, at the U.S. Supreme Court in Washington, U.S., April 24, 2024. REUTERS/Kevin Lamarque/File Photo U.S. President Donald Trump's administration on Tuesday rescinded guidance issued during his Democratic predecessor Joe Biden's tenure requiring hospitals to provide abortions to women in medical emergencies regardless of various state bans on the procedure. The U.S. Centers for Medicare & Medicaid Services said the 2022 guidance, which interpreted a federal law that ensures patients can receive emergency "stabilizing care" as preempting state abortion bans, did not reflect the policy of the Trump administration. The agency, which is part of the U.S. Department of Health and Human Services, said it "will work to rectify any perceived legal confusion and instability created by the former administration's actions." The Biden administration issued the guidance in July 2022 weeks after the 6-3 conservative majority U.S. Supreme Court overturned its 1973 Roe v. Wade ruling that had recognized a nationwide right of women to obtain abortions. The 2022 guidance reminded healthcare providers across the country of their obligations under a 1986 federal law called the Emergency Medical Treatment and Labor Act (EMTALA) to ensure Medicare-participating hospitals offer emergency care stabilizing patients regardless of their ability to pay. Medicare is the government healthcare program for the elderly. Hospitals that violate EMTALA risk losing Medicare funding. The 2022 guidance aimed to make clear that under EMTALA, physicians must provide a woman an abortion if needed to resolve a medical emergency and stabilize the patient even in states where the procedure is banned and that the federal law preempted any state laws that offer no exceptions for medical emergencies. After issuing the guidance, the U.S. Department of Justice sued the state of Idaho in a bid to stop it from enforcing its near-total abortion ban in medical emergencies. A federal judge at the Justice Department's urging blocked the Idaho from enforcing the ban during medical emergencies, but the Trump administration in March dropped that lawsuit, resulting in that injunction being lifted. The ban still remains blocked in emergencies due to a similar lawsuit brought by a hospital system. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store